Kevin D. Coop's most recent trade in Definitive Healthcare Corp - Ordinary Shares - Class A was a trade of 2,382,892 Class A Common Stock done . Disclosure was reported to the exchange on March 1, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Definitive Healthcare Corp... | Kevin D. Coop | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 2,382,892 | 3,739,131 | - | 0 | Class A Common Stock | |
Definitive Healthcare Corp... | Kevin D. Coop | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jul 2024 | 186,192 | 1,356,239 | - | 0 | Class A Common Stock | |
Definitive Healthcare Corp... | Kevin D. Coop | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 1,170,047 | 1,170,047 | - | 0 | Class A Common Stock | |
Definitive Healthcare Corp... | Kevin D. Coop | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 1,137,038 | 1,137,038 | - | - | Performance-based Stock Units | |
Dun & Bradstreet Holdings Inc | Kevin D. Coop | President, North America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 241,255 | 1,019,583 | - | 0 | Common Stock | |
Dun & Bradstreet Holdings Inc | Kevin D. Coop | President, North America | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.58 per share. | 10 Mar 2022 | 14,042 | 1,005,541 | - | 16.6 | 232,816 | Common Stock |